{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:06:12Z","timestamp":1779321972723,"version":"3.51.4"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We evaluated low-dose infliximab (5\u2005mg\/kg) as adjunctive therapy in 20 patients with severe central nervous system tuberculosis. At 3 months, 60% achieved disability-free survival (modified Rankin Scale \u2264 2), and 75% showed clinically meaningful improvement. Our outcomes matched reports of high-dose infliximab. Randomized trials to optimize dosing are needed.<\/jats:p>","DOI":"10.1093\/cid\/ciaf573","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:20:14Z","timestamp":1760530814000},"page":"852-856","source":"Crossref","is-referenced-by-count":0,"title":["Role of Low-Dose Infliximab for Inflammatory Complications of Central Nervous System Tuberculosis: A Retrospective Cohort Study"],"prefix":"10.1093","volume":"82","author":[{"given":"Selwyn Selva","family":"Kumar D","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Christian Medical College , Vellore, Tamil Nadu ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1693-4422","authenticated-orcid":false,"given":"Nishi","family":"Somarkutty","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Christian Medical College , Vellore, Tamil Nadu ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayavelu Hariram","family":"Prasad D","sequence":"additional","affiliation":[{"name":"Department of Radiology, Christian Medical College , Vellore, Tamil Nadu ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Gautam","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Christian Medical College , Vellore, Tamil Nadu ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-2155","authenticated-orcid":false,"given":"Veerasamy","family":"Nagaraj","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Christian Medical College , Vellore, Tamil Nadu ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5561-036X","authenticated-orcid":false,"given":"Rajiv","family":"Karthik","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Christian Medical College , Vellore, Tamil Nadu ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4321-7221","authenticated-orcid":false,"given":"Harshad Arvind","family":"Vanjare","sequence":"additional","affiliation":[{"name":"Department of Radiology, Christian Medical College , Vellore, Tamil Nadu ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2008-1808","authenticated-orcid":false,"given":"Prabhakar Thirumal","family":"Appaswamy","sequence":"additional","affiliation":[{"name":"Department of Neurology, Christian Medical College , Vellore, Tamil Nadu ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy Sarojini","family":"Michael","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Christian Medical College , Vellore, Tamil Nadu ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4040-5649","authenticated-orcid":false,"given":"George M","family":"Varghese","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Christian Medical College , Vellore, Tamil Nadu ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abi","family":"Manesh","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Christian Medical College , Vellore, Tamil Nadu ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"2026052019240174200_ciaf573-B1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol Ther"},{"key":"2026052019240174200_ciaf573-B2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/sj.jidsymp.5650027","article-title":"Tumor necrosis factor and tuberculosis","volume":"12","author":"Lin","year":"2007","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2026052019240174200_ciaf573-B3","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"2026052019240174200_ciaf573-B4","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/592695","article-title":"Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes","volume":"47","author":"Blackmore","year":"2008","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"2026052019240174200_ciaf573-B5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/430914","article-title":"Reconsidering adjuvant immunotherapy for tuberculosis","volume":"41","author":"Wallis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2026052019240174200_ciaf573-B6"},{"key":"2026052019240174200_ciaf573-B7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1473-3099(10)70138-9","article-title":"Tuberculous meningitis: a uniform case definition for use in clinical research","volume":"10","author":"Marais","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2026052019240174200_ciaf573-B8","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/cid\/ciad401","article-title":"Effectiveness of adjunctive high-dose infliximab therapy to improve disability-free survival among patients with severe central nervous system tuberculosis: a matched retrospective cohort study","volume":"77","author":"Manesh","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026052019240174200_ciaf573-B9","doi-asserted-by":"crossref","first-page":"e235511","DOI":"10.1136\/bcr-2020-235511","article-title":"Potential disease trigger as a therapeutic option: infliximab for paradoxical reaction in tuberculosis of the central nervous system","volume":"14","author":"Briner","year":"2021","journal-title":"BMJ Case Rep"},{"key":"2026052019240174200_ciaf573-B10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10096-023-04564-2","article-title":"The use of TNF-\u03b1 antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review","volume":"42","author":"Armange","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026052019240174200_ciaf573-B11","doi-asserted-by":"crossref","first-page":"ofaa604","DOI":"10.1093\/ofid\/ofaa604","article-title":"Use of infliximab to treat paradoxical tuberculous meningitis reactions","volume":"8","author":"Marais","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2026052019240174200_ciaf573-B12","doi-asserted-by":"crossref","first-page":"e22626","DOI":"10.1097\/MD.0000000000022626","article-title":"Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis: case report and review","volume":"99","author":"Santin","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2026052019240174200_ciaf573-B13","doi-asserted-by":"crossref","first-page":"e39012","DOI":"10.1097\/MD.0000000000039012","article-title":"Safety of TNF-\u03b1 inhibitors: a real-world study based on the US FDA adverse event reporting system database","volume":"103","author":"Zheng","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"2026052019240174200_ciaf573-B14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.10302","article-title":"The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial","volume":"46","author":"St Clair","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2026052019240174200_ciaf573-B15","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.cmi.2023.03.021","article-title":"Which trial do we need? A global, adaptive, platform trial to reduce death and disability from tuberculous meningitis","volume":"29","author":"Thwaites","year":"2023","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf573\/67419170\/ciaf573.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/5\/852\/67419170\/ciaf573.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/5\/852\/67419170\/ciaf573.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:24:08Z","timestamp":1779319448000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/5\/852\/8529344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,20]]},"published-print":{"date-parts":[[2026,5,20]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf573","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,15]]},"published":{"date-parts":[[2026,3,20]]}}}